2022
Lung Organoids-The Ultimate Tool to Dissect Pulmonary Diseases?
BOSÁKOVÁ, Veronika, Marco DE ZUANI, Lucie SLÁDKOVÁ, Zuzana GARLÍKOVÁ, Shyam SUSHAMA JOSE et. al.Základní údaje
Originální název
Lung Organoids-The Ultimate Tool to Dissect Pulmonary Diseases?
Autoři
BOSÁKOVÁ, Veronika (203 Česká republika, domácí), Marco DE ZUANI (380 Itálie), Lucie SLÁDKOVÁ (203 Česká republika), Zuzana GARLÍKOVÁ (203 Česká republika), Shyam SUSHAMA JOSE (356 Indie), Teresa ZELANTE (380 Itálie), Marcela HORTOVÁ KOHOUTKOVÁ (203 Česká republika) a Jan FRIČ (203 Česká republika, garant)
Vydání
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, LAUSANNE, FRONTIERS MEDIA SA, 2022, 2296-634X
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10601 Cell biology
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 5.500
Kód RIV
RIV/00216224:14110/22:00126339
Organizační jednotka
Lékařská fakulta
UT WoS
000886940200001
Klíčová slova anglicky
3D structure; chronic obstructive pulmonary disease; cystic fibrosis - CF; human disease modelling; induced pluripotent stem cells; lung cancer; lung organoids
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 20. 2. 2023 09:00, Mgr. Tereza Miškechová
Anotace
V originále
Organoids are complex multicellular three-dimensional (3D) in vitro models that are designed to allow accurate studies of the molecular processes and pathologies of human organs. Organoids can be derived from a variety of cell types, such as human primary progenitor cells, pluripotent stem cells, or tumor-derived cells and can be co-cultured with immune or microbial cells to further mimic the tissue niche. Here, we focus on the development of 3D lung organoids and their use as disease models and drug screening tools. We introduce the various experimental approaches used to model complex human diseases and analyze their advantages and disadvantages. We also discuss validation of the organoids and their physiological relevance to the study of lung diseases. Furthermore, we summarize the current use of lung organoids as models of host-pathogen interactions and human lung diseases such as cystic fibrosis, chronic obstructive pulmonary disease, or SARS-CoV-2 infection. Moreover, we discuss the use of lung organoids derived from tumor cells as lung cancer models and their application in personalized cancer medicine research. Finally, we outline the future of research in the field of human induced pluripotent stem cell-derived organoids.
Návaznosti
MUNI/A/1418/2021, interní kód MU |
|